Dr. Young Kwon, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $204,259 | 60 | 99.9% |
| Food and Beverage | $163.07 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $204,259 | 60 | $0 (2024) |
| Novocure Inc. | $147.45 | 1 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $15.62 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89,584 | 25 | Takeda Pharmaceuticals U.S.A., Inc. ($89,584) |
| 2023 | $57,481 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($57,333) |
| 2022 | $57,342 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($57,342) |
| 2021 | $15.62 | 1 | BOSTON SCIENTIFIC CORPORATION ($15.62) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 01/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.36 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,583.34 | General |
About Dr. Young Kwon, MD
Dr. Young Kwon, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1043548209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Young Kwon, MD has received a total of $204,422 in payments from pharmaceutical and medical device companies, with $89,584 received in 2024. These payments were reported across 62 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($204,259).
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties General Practice
- Location Dallas, TX
- Active Since 11/30/2009
- Last Updated 05/08/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043548209
Products in Payments
- ACQUIRE (Device) $15.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Dallas
Dr. Amarinder Bindra
Student in an Organized Health Care Education/Training Program — Payments: $605,555
Ambarish Pandey, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $556,167
Mary Horner, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $256,186
Dr. Allison Dipasquale, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $252,903
Michael Siah
Student in an Organized Health Care Education/Training Program — Payments: $211,953
Dr. Jaime Almandoz, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $138,928